Kumud Kalia, the Chief Information Officer of $GH, sold 26,980 shares of the company on 03-04-2026 for an estimated $2,566,310. We received data on the trade from a recent SEC filing. This was a sale of approximately 34.7% of their shares of this class of stock. Following this trade, they now own 50,663 shares of this class of $GH stock.
$GH Insider Trading Activity
$GH insiders have traded $GH stock on the open market 67 times in the past 6 months. Of those trades, 0 have been purchases and 67 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- HELMY ELTOUKHY (Co-Chief Executive Officer) has made 0 purchases and 4 sales selling 390,565 shares for an estimated $27,238,215.
- AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 6 sales selling 100,000 shares for an estimated $10,505,473.
- MICHAEL BRIAN BELL (Chief Financial Officer) has made 0 purchases and 12 sales selling 80,362 shares for an estimated $8,288,741.
- TERILYN J. MONROE (Chief People Officer) has made 0 purchases and 13 sales selling 73,769 shares for an estimated $7,948,344.
- KUMUD KALIA (Chief Information Officer) has made 0 purchases and 3 sales selling 42,000 shares for an estimated $4,021,864.
- CHRIS FREEMAN (Chief Commercial Officer) has made 0 purchases and 11 sales selling 31,452 shares for an estimated $3,241,621.
- IAN T CLARK has made 0 purchases and 3 sales selling 28,611 shares for an estimated $3,066,817.
- DARYA CHUDOVA (Chief Technology Officer) has made 0 purchases and 3 sales selling 28,386 shares for an estimated $2,985,111.
- JOHN G. SAIA (Chief Legal Officer) sold 8,996 shares for an estimated $865,865
- MEDINA MANUEL HIDALGO has made 0 purchases and 5 sales selling 4,915 shares for an estimated $391,280.
- MUSA TARIQ has made 0 purchases and 4 sales selling 464 shares for an estimated $37,153.
- MYRTLE S POTTER has made 0 purchases and 2 sales selling 52 shares for an estimated $3,187.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GH Hedge Fund Activity
We have seen 280 institutional investors add shares of $GH stock to their portfolio, and 207 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,131,895 shares (-78.8%) from their portfolio in Q4 2025, for an estimated $728,451,755
- WELLINGTON MANAGEMENT GROUP LLP removed 2,842,566 shares (-87.5%) from their portfolio in Q4 2025, for an estimated $290,339,691
- ALLIANCEBERNSTEIN L.P. added 1,761,785 shares (+1262.7%) to their portfolio in Q4 2025, for an estimated $179,948,719
- FMR LLC added 1,572,168 shares (+190.7%) to their portfolio in Q4 2025, for an estimated $160,581,239
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,414,441 shares (+33.5%) to their portfolio in Q4 2025, for an estimated $144,471,003
- POINT72 ASSET MANAGEMENT, L.P. added 1,396,754 shares (+1363.8%) to their portfolio in Q4 2025, for an estimated $142,664,453
- DEEP TRACK CAPITAL, LP removed 1,354,086 shares (-32.6%) from their portfolio in Q4 2025, for an estimated $138,306,344
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GH Revenue
$GH had revenues of $281.3M in Q4 2025. This is an increase of 39.37% from the same period in the prior year.
You can track GH financials on Quiver Quantitative's GH stock page.
$GH Congressional Stock Trading
Members of Congress have traded $GH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GH stock by members of Congress over the last 6 months:
- SENATOR SHELDON WHITEHOUSE purchased up to $15,000 on 11/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$GH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 15 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/20/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- Mizuho issued a "Outperform" rating on 12/17/2025
- UBS issued a "Buy" rating on 10/30/2025
- Evercore ISI Group issued a "Outperform" rating on 10/30/2025
- Citigroup issued a "Buy" rating on 10/30/2025
- Barclays issued a "Overweight" rating on 10/30/2025
To track analyst ratings and price targets for $GH, check out Quiver Quantitative's $GH forecast page.
$GH Price Targets
Multiple analysts have issued price targets for $GH recently. We have seen 17 analysts offer price targets for $GH in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $130.0 on 02/24/2026
- Daniel Arias from Stifel set a target price of $130.0 on 02/20/2026
- Puneet Souda from Leerink Partners set a target price of $180.0 on 02/20/2026
- Dan Brennan from TD Cowen set a target price of $135.0 on 02/20/2026
- Brandon Couillard from Wells Fargo set a target price of $125.0 on 02/20/2026
- Casey Woodring from JP Morgan set a target price of $130.0 on 02/20/2026
- Kyle Mikson from Canaccord Genuity set a target price of $135.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
